I
n the realm of modern biotechnology, the
elucidation of the human genome has ushered in an era of unprecedented scientific discovery and innovation. This remarkable feat has
not only deepened our understanding of human
biology but has also presented unique opportunities and challenges at the intersection of science,
law, and ethics. Central to these discussions is
the practice of patenting human genes, a contentious issue that has sparked debates on the ownership, accessibility, and ethical implications of
genetic information.
The patenting of human genes represents a
significant milestone in the history of intellectual
property law and biomedical innovation.